Alsanza Launches First Fourier Transformed Optic Technology In The IOLs
ID: 1841060
Alsanza GmbH announces the launch of Alsafit Fourier Optic IOL. Alsafit Fourier total presbyopia correcting IOL with Optic design is developed to achieve perfect vision at all distances and light conditions.
Alsafit Fourier is a total presbyopia correcting IOL for cataract and RLE surgery procedures. By carrying a disruptive innovation in optical design, Fourier Optic is fitted out with reverse apodization in all optical zone (6mm). This unique pattern is developed by transforming classical edged overlapping Fresnel diffraction into Fourier Optic with reverse apodization. Throughout reverse apodized Fourier Optic, it consists of 14 soft transition steps which support possessing high quality of vision at all distances regardless of lighting condition.
Why Reverse Apodization?
Reverse Apodization maintains continuity of balanced light distribution and continuous focus regardless of lighting conditions. Patent pending Fourier Optic with Reverse apodization features 24H Balanced Light Distribution that enables high energy distribution to near and intermediate in mesopic conditions as well as photopic. That unique design promises patients more efficent light distribution and have clear vision at all distances during daytime and nighttime.
For more information, visit https://alsanza.com/ophthalmology/total-presbyopia-correcting-iol/alsafit-fourier/
Alsanza Medizintechnik und Pharma GmbH founded and headquartered in Pfullingen, Germany. Since 2011, bringing the best out of the market from an exclusive owned production. The company is offering a large portfolio of Intraocular lenses, Viscoelastics and Eye Irrigating Solutions (BSS). Conception, development and manufacture are exclusively performed in-house.
Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
Alsanza Medizintechnik und Pharma GmbH founded and headquartered in Pfullingen, Germany. Since 2011, bringing the best out of the market from an exclusive owned production. The company is offering a large portfolio of Intraocular lenses, Viscoelastics and Eye Irrigating Solutions (BSS). Conception, development and manufacture are exclusively performed in-house.
Datum: 02.09.2020 - 13:02 Uhr
Sprache: Deutsch
News-ID 1841060
Anzahl Zeichen: 2528
Kontakt-Informationen:
Stadt:
Pfullingen, Germany
Kategorie:
Optische Technologien
Diese Pressemitteilung wurde bisher 833 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Alsanza Launches First Fourier Transformed Optic Technology In The IOLs"
steht unter der journalistisch-redaktionellen Verantwortung von
Alsanza Medizintechnik und Pharma GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).